Stay updated on Pembrolizumab Combos in mCRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combos in mCRC Clinical Trial page.

Latest updates to the Pembrolizumab Combos in mCRC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedPublications note text updated: added a sentence clarifying that publications are provided voluntarily and relate to study results, and the previous wording was removed; the revision/version label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedRemoved an administrative notice about government operating status from the page; this does not affect the study details or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check49 days agoChange DetectedNo significant changes to core trial information or page structure were observed; the page content, including the study title, NCT03374254 identifier, and eligibility criteria, remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check70 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check77 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.0%

- Check92 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; no substantive core content changes are evident. The 'Back to Top' element was removed, a minor UI change.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combos in mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combos in mCRC Clinical Trial page.